Clinical Trials Browser

Phase EARLY_PHASE1 × Metastatic Pancreatic Adenocarcinoma × Gastrointestinal × Clear all

NCT02847000 2019-01-09

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer

Phase EARLY_PHASE1 Completed

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma